Sykon Capital’s Pfizer PFE Stock Holding History

Sykon Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$394K	Hold	14,014	–	–	0.13%	62
2025 Q4	$349K	Hold	14,014	–	–	0.11%	94
2025 Q3	$357K	Buy	14,014 +2,000	+17%	+$49.4K	0.12%	84
2025 Q2	$291K	Hold	12,014	–	–	0.11%	69
2025 Q1	$304K	Hold	12,014	–	–	0.12%	50
2024 Q4	$319K	Hold	12,014	–	–	0.11%	51
2024 Q3	$348K	Hold	12,014	–	–	0.12%	72
2024 Q2	$336K	Hold	12,014	–	–	0.13%	67
2024 Q1	$333K	Hold	12,014	–	–	0.12%	77
2023 Q4	$346K	Hold	12,014	–	–	0.14%	62
2023 Q3	$399K	Sell	12,014 -691	-5%	-$24.4K	0.17%	38
2023 Q2	$466K	Buy	+12,705	New	+$495K	0.32%	33

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Sykon Capital's PFE Position: Q1 2026 in Review

Sykon Capital held its Pfizer (PFE) position steady in Q1 2026 at 14,014 shares worth $394K. The position accounts for 0.13% of the portfolio, ranked #62.

Sykon Capital first reported a position in PFE in Q2 2023 and has held it in 12 quarters since. The position peaked at $466K in Q2 2023. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Sykon Capital held 14,014 shares of Pfizer worth $394K as of Q1 2026.
Sykon Capital left its Pfizer share count unchanged in Q1 2026.
Pfizer made up 0.13% of Sykon Capital's portfolio in Q1 2026, its #62 holding.
Sykon Capital first reported a position in Pfizer in Q2 2023 and has held it in 12 quarters since.
Sykon Capital's Pfizer position peaked at $466K in Q2 2023.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Sykon Capital's 13F filing for Q1 2026, filed 22 Apr 2026.